CD8A and hepatocellular carcinoma: In this study, we demonstrated positive immunomodulatory changes explicitly in terms of CD8+ T-cells and Tregs, following the liver resection in HCC patients using the RF-based device HabibTM 4X, compared to CUSA, which may account for the observed better survival in the same group.